Page last updated: 2024-12-11

s 22153

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9816339
SCHEMBL ID1924859
MeSH IDM0332143

Synonyms (14)

Synonym
n-[2-(5-ethyl-1-benzothiophen-3-yl)ethyl]acetamide
s-22153
gtpl1361
s22153 ,
s 22153
L015225
SCHEMBL1924859
n-(2-(5-ethylbenzo[b]thiophen-3-yl)ethyl)acetamide
Q27088665
180304-07-8
HY-114962
STARBLD0003449
CS-0064703
AKOS040749387
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1346274Human MT2 receptor (Melatonin receptors)2003Naunyn-Schmiedeberg's archives of pharmacology, Jun, Volume: 367, Issue:6
New selective ligands of human cloned melatonin MT1 and MT2 receptors.
AID1346220Human MT1 receptor (Melatonin receptors)2003Naunyn-Schmiedeberg's archives of pharmacology, Jun, Volume: 367, Issue:6
New selective ligands of human cloned melatonin MT1 and MT2 receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (20.00)18.2507
2000's9 (60.00)29.6817
2010's3 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.63 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]